Navigation Links
Instacare Corp. Board of Directors Sets Growth Plans for 2010
Date:12/17/2009

LOS ANGELES, Dec. 17 /PRNewswire-FirstCall/ -- Instacare Corp. (OTC Bulletin Board: ISCR) a publicly-traded leading provider of life-saving and life-enhancing prescription drugs and diagnostics and at home testing products for the chronically ill, and a leading developer and provider of e-health technologies and revolutionary cell phone centric technologies and products announced today that as part of the preparation of its Fiscal 2010 guidance, the Board has determined to add two new Directors and has rejected, as unneeded, multiple offers for equity or convertible financing.

Instacare Chairman Robert Jagunich commented, "Two additional Board members are expected to join the company's Board of Directors within the next ten days. At least one of the leading candidates to join our Board has contributed greatly to our Board in the past. All of the candidates we are considering have decades of healthcare industry experience and have served on policy boards that among other things set Medicare standards and policy (reimbursement). These special individuals will strengthen the company's position as a leading fulfillment provider of direct-to-patient diabetes programs and help the company exploit the sweet spot provided by the national health plan nearing completion in Congress."

In addition to the company's intent to add experience, knowledge and special skill to its Board of Directors, Instacare also announced that the Board has declined to accept any of the multiple financing offers it has received from investment banks, boutiques, funds and wealthy individuals. The Board has terminated all discussions in this regard believing that the company is well enough financed and there is no need for equity or convertible debt financing at current levels. This news follows recent statements by the company that management has been approached by two large healthcare firms, expressing interest in furnishing Instacare's cell-phone ready EMR products to their physician provider networks. Subsequently a third large company has approached the company.

Instacare believes that no other market provider offers physicians, hospitals and other medical professionals a comparable suite of robust, secure internet-based EMR and patient medical history applications, and proposed treatment protocols. The company's cell phone centric business model employs and exploits the power of the Internet when used in conjunction with popular smart cell phones such as Apple iPhone, Palm Pre, Blackberry and Windows phones. The company's proprietary technologies enable the storage of a main-frame computer that can be put to work right in the palm of the physician's hand after just 15 minutes of training.

Forward-Looking Statements

This news release contains forward-looking statements about our business, or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions.

For more information please contact Keith Berman, CFO of Instacare Corp. at (805) 446-1973, or you can visit the company's web site www.instacare.net

SOURCE Instacare Corp.


'/>"/>
SOURCE Instacare Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Instacare Moves to Secure Patents for Its Newest Technologies, Announces Parallel Strategies for Its Revolutionary MD@Hand Cell-Centric Products
2. instaCare Corp. Continues Turnaround, Reports 58% Revenues Increase for First Three Quarters
3. BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronies Disease
4. Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
5. Cantel Medical Corp. to Hold Conference Call to Discuss Results for its First Quarter Ended October 31, 2009
6. Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology
7. BioSpecifics Technologies Corp. to Present at the Piper Jaffray 21st Annual Health Care Conference
8. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
9. Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
10. Cantel Medical Corp. to Present at the Sidoti Emerging Growth Research Institutional Investor Forum
11. WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... and INDIANAPOLIS , June ... receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship is any ... scholarship winners, announced today online at www.diabetesscholars.org ... type 1 diabetes stand in the way of academic ... supported the Foundation,s scholarship program since 2012, and continues ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned by ... to enhance the health of felines. The formula is all-natural and is made from ... the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root Extract ...
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
Breaking Medicine News(10 mins):